Search Results 201-210 of 17047 for hla genotype

  1. A Study to Explore Ghrelin Levels with Primary Graft Dysfunction in Lung Transplant Recipients - Mayo Clinic

    The purpose of this study is to investigate ghrelin, a peptide that mechanistically carries the promise of therapeutics benefit for diverse aspects of morbidity ...

  2. Study of Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK) - Mayo Clinic

    Recipients of non- Human Leukocyte Antigen (HLA) identical living or deceased donor renal transplants. Protocol renal allograft biopsy at 5 months (± 8 ...

  3. A Study To Evaluate ALN-6400 In Healthy Volunteers And Patients With Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    About this study. The purpose of this study is to: * evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending ...

  4. Safety & Efficacy Of Intramyocardial Injection Of Mesenchymal Precursor Cells On Myocardial Function In LVAD Recipients - Mayo Clinic

    Presence of >10% anti-HLA antibody titers with known specificity to MPC donor HLA antigens; A known hypersensitivity to dimethyl sulfoxide (DMSO), murine ...

  5. Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia - Mayo Clinic

    Patient should be human leukocyte antigen (HLA) typed (A, B, C, DR and DQ) during induction therapy phase or a written explanation for not undergoing HLA typing ...

  6. Radhika Dhamija, M.B.B.S. - Mayo Clinic Faculty Profiles

    Dhamija focuses on neurogenetics and has written many publications describing new genotype-phenotype correlations, including a new syndrome called Hartsfield ...

  7. A Study to Evaluate Molecular and Biochemical Testing for Suspected Hereditary Disorders - Mayo Clinic

    About this study. The objectives of this study are to perform molecular and/or biochemical testing in individuals with suspected hereditary disorders, ...

  8. Neurology - Clinical trials

    ... genotype, including understudied APOE2 and APOE4 homozygotes (HMs) at the lowest and highest risk and those APOE4 HMs and heterozygotes (HTs) who remain ...

  9. Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) - Mayo Clinic

    Patients with an unrelated HLA-A,-B, -C and -DRBI matched donor; Patients with a Karnofsky Performance Score ≥ 70%. Key Exclusion Criteria: Clinically ...

  10. Neurology - Clinical trials - Mayo Clinic

    ... genotype, including understudied APOE2 and APOE4 homozygotes (HMs) at the lowest and highest risk and those APOE4 HMs and heterozygotes (HTs) who remain ...